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Objective: The high risk of nonunion represents a challenge in vertebral surgery, thus stimulating new
strategies to improve fusion rates. We investigated the effect of 2 different bone grafts and amniotic ﬂuidKey words:
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application on radiologically and histologically evaluated vertebral fusion in an experimental rat model.
Materials and methods: Forty-eight 24-week-old Sprague Dawley rats were included and assigned into
1 of 4 groups: allograft group, allograft plus human amniotic ﬂuid group, demineralized bone matrix
(DBM) group, or DBM plus human amniotic ﬂuid group. After decortication and L4–L6 spinal fusion,
study treatments were applied. Fusion in each rat was examined radiologically and histologically 8 weeks
after the intervention.
Results: The group that received only allograft had better radiologic scores (median ¼ 3.5; range ¼ 3–4)
when compared with the group that received only DBM (median ¼ 2; range ¼ 1–4) (P ¼ 0.002);
however, histologic scores did not differ. When amniotic ﬂuid was added to the grafting, allograft-based
treatments performed better than DBM-based treatments both on radiologic (median ¼ 4; range ¼ 3–4
vs median ¼ 3; range ¼ 3–4; P ¼ 0.003) and histologic (median ¼ 7; range ¼ 6–7 vs median ¼ 5; range
¼ 3–6; P o 0.001) evaluation. Addition of amniotic ﬂuid did not result in better outcomes in the rats that
received DBM-based treatments but based on histologic evaluation, rats that received allograft-based
treatments beneﬁted from this application.
Conclusions: Amniotic ﬂuid seems to have an enhancing effect on posterior spinal fusion, particularly
when combined with allograft.
& 2015. The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Advances in the ﬁeld of vertebral surgery have inevitably placed
more signiﬁcance on fusion surgery, which is still associated with a
10% to 15% risk of nonunion even in the presence of internal
ﬁxation.1 In addition, it is a well-known fact that nonunion often
requires revision surgery due to patient dissatisfaction.
Vertebral fusion demands a concerted effect of certain biologic
and mechanical factors.1 Although the former of these includes the
extraction of joint cartilage, decortication, grafting, and immobili-
zation of the segment to be fused, the latter involves the use of
ﬁxation equipment such as rods, plaques, wires, hooks, plasters,
corsets, and a variety of apparatuses.2 Reinforcing the fusion withInc. This is an open access article u
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an).solid internal ﬁxation does not exclude the possibility of nonunion,
again placing increasing emphasis on biologic factors.
A number of studies have been undertaken to investigate
alternative strategies, particularly looking at alternatives to bone
grafts at a clinical level,2 due to the high rate of nonunion and
donor site morbidity following the use of autografts in primary
spinal fusion surgery.2 In this regard, demineralized bone matrix
(DBM) represents a readily available graft alternative with osteoin-
ductive potential that has shown promising results in several
studies.3,4
Several mediator molecules with anabolic effects such as the
transforming growth factor, ﬁbroblast growth factor (FGF), platelet-
derived growth factor, interleukin-1, and interleukin-6 can also
provide additional beneﬁt in these procedures.5 Potentially similar
growth and trophic factors include insulin-like growth factor (IGF)-I
and IGF-II and epidermal growth factor. Speciﬁcally, IGF-I and IGF-II
are growth factors that are known to be associated with matrix
synthesis during the bone recovery phase.6nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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of certain extracellular macromolecules such as epidermal growth
factor, IGF-I, IGF-II, FGF, ﬁbronectin and laminin,7,8 hyaluronic acid
(HA) (which is a high molecular weight polysaccharide that is
abundant in body ﬂuids and in connective tissue), chondroitin
sulphate, and an HA activating factor.7,8 HA is particularly found in
soft connective tissues, with some osteoblastic bone-forming effect.7
The role of amniotic ﬂuid, which has a variety of biologic features in
vertebral fusion, has been the subject of very few studies until now.
We investigated the effect of bone grafts (allograft or DBM) and
amniotic ﬂuid on vertebral fusion in an experimental rat vertebral
fusion model.Materials and Methods
Experimental animals and study groups
The study conformed to the Turkish national recommendations
of the ethics committees for animal research, in line with the
European Commission Directive 86/609/EEC for animal experiments.
A total of 48 Sprague Dawley rats with a mean weight of 250 g
(range ¼ 200–300 g) and age of 24 weeks were included in this
study. Animals were placed in cages of 2 and were kept at a stable
temperature of 201C to 241C with 12 hours of dark and 12 hours of
light cycles. Rats were assigned into 4 groups consisting of 12 rats in
each: Group I had allograft only, Group II had allograft plus human
amniotic ﬂuid, Group III had DBM only, and Group IV had DBM plus
human amniotic ﬂuid application. Fusion in each rat was examined
radiologically and histologically 8 weeks after the experimental
application of the study treatments following experimental decorti-
cation and spinal fusion between the fourth and sixth vertebrae.
Preparation of allografts and DBM
To obtain allografts and DBM, 8 rats that were not included in
the study were killed, after which both iliac wings, femur, and tibia
were stripped off from the soft tissues. Iliac wings were used to
obtain allografts.
To prepare DBM, femurs and tibias were frozen at –701C after
removal of the soft tissues. Sterilization was carried out by ethyl-
ene oxide. Fragments of 0.5 mm were dissected to obtain DBM.
They then were ground to achieve fragments with an average
dimension of 106 to 500 μm. The decalciﬁcation process was
completed by storing the material for 16 hours at 41C in 0.6 normal
hydrochloric acid (N HCL) (100 g/2 L). Materials were then washed
in sterile water and soaked in 70% ethanol. DBM was dried using a
vacuum dryer overnight, sterilized with ethylene oxide, and kept
at –701C.
Preparation of amniotic ﬂuid
Amniotic ﬂuid was obtained from pregnant women attending
the obstetrics outpatient unit in our hospital who completed 20
weeks of pregnancy and signed an informed consent. Centrifuga-
tion was performed using a Heraeus Sepatech Megafuge 1.0R
(Langenselbold, Germany) device at 4300 revolutions/min for 15
minutes. About 0.1 cc precipitate was obtained from this proce-
dure. The remaining 8 cc supernatant was taken and kept at –201C.
Amniotic ﬂuid to be used in surgery was thawed by keeping at
room temperature for 20 minutes.
Surgical methods and follow-up
In anesthetized rats in the prone position, a surgical midline
incision was made on the lumbar region along the spinousprocesses. After skin, subcutaneous tissue, and fascia were incised,
the longissimus lumbarum muscle, which is localized posteriorly,
was stripped off and spinous processes and transverse processes
were exposed. Spinal fusion was performed in L4 to L6. Spinous
processes of the lumbar vertebrae were taken off by rongeur and
bones were cleared of their soft tissues. Transverse processes were
decorticated. The lumbar region in which the graft was placed was
decorticated with rongeur, curette, and thin burr. In Groups I and
III, grafts were applied without amniotic ﬂuid (ie, allograft only in
Group I and DBM only in Group III). In Group II and Group IV, in
addition to allograft or DBM, 0.5 cc processed amniotic ﬂuid was
applied to the posterior spinal elements that were decorticated
following fusion with grafts.
During the ﬁrst 7 days of postsurgical follow-up, wound
dressings and examination of the surgical site were performed.
Immobilization was not implemented. Rats were killed at Week
8 using high-dose ether anesthesia. Cervical dislocation was not
performed on rats because it could affect the fusion. The fusion
line was accessed through a posterior midline incision involving
the skin, subcutaneous tissue, and muscle layer. The fusion area
was carefully dissected with bone scissors avoiding injury to the
fusion site at its proximal and distal ends. The removed segments
with fusion were placed in bottles containing 10% formaldehyde.
Radiologic evaluations
Each fusion segment extracted was assigned a number and
placed on a 30  24 cm radiograph cassette so that tube distance
was 90 cm. Then anteroposterior radiographs digitally shot were
evaluated. Radiographic images were evaluated by a single radiol-
ogist who was blinded to the type of grafting implemented.
Radiologic assessments were based on Lenke’s radiologic evalua-
tion system9 using a 1- to 4-point scale, where 1 ¼ bilateral graft
resorption or fusion mass with obvious bilateral pseudarthrosis;
2 ¼ bilateral small, thin fusion masses; 3 ¼ unilateral large fusion
mass with contralateral small fusion mass; and 4 ¼ solid large
trabeculated bilateral fusion masses.
Histologic examinations
Samples from which radiologic images were obtained after the
rats were killed were decalciﬁed in 10% formic acid at room
temperature for 80 days. Decalciﬁcation solution was changed
every 3 days during this period. Samples were dehydrated with
ethanol, cleaned with xylene, and buried in parafﬁn. Longitudinal
sections of 5 μm were done by microtome knife and hematoxylin-
eosin stain was applied. All cross-sections were evaluated with a
light microscope (Olympus BX-51, Postfach, Hamburg, Germany) at
the histology laboratory and microphotographs were obtained. A
0- to 7-point scaling system described by Emery et al10 was used
for histopathologic evaluations, where 0 ¼ empty cleft, 1 ¼
ﬁbrous tissue only, 2 ¼ more ﬁbrous tissue than ﬁbrocartilage, 3
¼ more ﬁbrocartilage than ﬁbrous tissue, 4 ¼ ﬁbrocartilage only, 5
¼ more ﬁbrocartilage than bone, 6 ¼ more bone than ﬁbrocarti-
lage, and 7 ¼ bone only.
Statistical analyses
Statistical evaluation was done using SPSS 13.0 for Windows
(IBM-SPSS Inc, Armonk, NY). Differences between the groups in
terms of scores were analyzed using Kruskal-Wallis variance
analysis and Mann-Whitney U test was used for pairwise compar-
isons. A P value o 0.05 was considered an indication of statistical
signiﬁcance for the variance analyses. For post-hoc analyses,
Bonferroni correction was made and the level of signiﬁcance was
set at P o 0.0083 for Mann Whitney U test.
A B
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Figure 1. Anteroposterior radiograph images of (A) allograft group, (B) allograft
plus amniotic ﬂuid group, (C) demineralized bone matrix group, and
(D) demineralized bone matrix plus amniotic ﬂuid group.
A B
C D
Figure 2. Histologic (hematoxylin-eosin staining [ 40]) images of (A) allograft
group, (B) allograft plus amniotic ﬂuid group, (C) demineralized bone matrix group,
and (D) demineralized bone matrix plus amniotic ﬂuid group. ¼ allograft;
¼ bone tissue; ¼ ﬁbrocartilage tissue.
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None of the rats had an immunologic reaction after local
administration of amniotic ﬂuid. During the 8-week period after
the intervention, none of the rats developed rash or purulent
discharge at the site of incision.
Comparison of allograft-based treatments versus DBM-based
treatments
Comparisons of the groups in terms of radiologic and histologic
scores and images are shown in Figures 1 and 2 and Table I. The
group that received only allograft (ie, no amniotic ﬂuid application)
had better radiologic scores (median ¼ 3.5; range ¼ 3–4) when
compared with the group that received only DBM without amniotic
ﬂuid (median ¼ 2; range ¼ 1–4) (P ¼ 0.002). However, these
2 groups did not differ with regard to histologic scores (median ¼
6; range ¼ 5–6 vs median ¼ 5; range ¼ 4–6) (P 4 0.0083). On the
other hand, when amniotic ﬂuid was added to the treatment,
allograft-based treatments performed better than DBM-based treat-
ments based both on radiologic (median ¼ 4; range ¼ 3–4 vs
median ¼ 3; range ¼ 3–4; P ¼ 0.003) and histologic (median ¼ 7;
range ¼ 6–7 vs median ¼ 5; range ¼ 3–6; P o 0.001) scores.
Effect of amniotic ﬂuid
Addition of amniotic ﬂuid did not result in better outcomes in
the rats that received DBM-based treatments. When the group that
received DBM only and the group that received DBM plus amniotic
ﬂuid were compared, no signiﬁcant differences was found in radio-
logic or histologic scores (P 4 0.0083 for both comparisons). On the
other hand, addition of amniotic ﬂuid to the allograft resulted in
better histologic scores (median ¼ 7; range ¼ 6–7 versus median ¼
6; range ¼ 5–6; P ¼ 0.001), but not better radiologic scores
(median ¼ 4; range ¼ 3–4 versus median ¼ 3.5; range ¼ 3–4).
Discussion
Posterior fusion is frequently performed for the surgical man-
agement of a number of conditions, including vertebra fractures,
spondylolisthesis, and vertebral instability. However, controversystill exists on the type of grafts to be used in these applications.
Although autografts represent the most commonly preferred
strategy, their disadvantages include their paucity and high mor-
bidity rates in graft sites. The volume of bone that can be used for
autografting may be limited.11 Presence of inﬂammatory and
osteogenic cells in the microanatomic environment and a healthy
blood ﬂow constitute the key elements of a successful spinal
arthrodesis. The few transplanted autologous cells that survive in
the fusion site can be a source for osteogenic cells.
Allografts, used in combination with autografts or as a substitute
for autografts, represent the most commonly used type of graft.
Bridwell et al12 found it convenient to use allografts in patients with
paralysis in whom obtaining autogenic bone is not possible. Several
studies have also demonstrated successful posterior fusion using
allografts in children. Although a high rate of compression is found
with allografts in the lumbar vertebra, an acceptable rate of fusion is
obtained in structural allografts supported with anterior autologous
bone grafts. Also, it needs to be taken into consideration that there
can be disadvantages to allografts—like the risk of bacterial-viral
infections and immunologic reactions—because they need cold-chain
during the time they are preserved and transferred. In a study where
29 patients treated with fresh frozen allograft were compared with
those treated with autografts, Brown et al13 did not ﬁnd any differ-
ence in terms of fusion and graft resorption. These abovementioned
studies examined single-level fusion and the authors pointed out
that higher rates of resorption occurs in multilevel fusions done with
allograft. Young and Rossenwasser14 performed fusion using ﬁbular
allografts and did not ﬁnd any difference in terms of postoperative
fusion success rates between ﬁbular allograft and iliac wing.
Although several studies have demonstrated that DBM is a
convenient graft alternative,3,4 there are scarce data on its use for
vertebral fusion. Several experimental animal models were devel-
oped to investigate the osteoinductive capacity of DBM or to
improve the biologic activity of autografts.3,4 Morone and Boden15
demonstrated that a low volume of autograft revealed similar results
with the fusion obtained by a mixture prepared with DBM gel. Many
experimental study models have been published reporting on the
effect of DBM. In a study conducted by Urist16 almost 40 years ago,
osteoinductive capacity of DBM was established. It was shown in
experiments and in a limited number of studies that DBM increased
Table I
Comparison of the groups in terms of radiologic and histologic scores.
Group Median (min–max) Group I Group II Group III Group IV
P value
Group I Radiologic scores 3 (3–4) 0.001* 0.002*
Histologic scores 6 (5–6) 40.0083 40.0083
Group II Radiologic scores 4 (3–4) 0.001* 0.003*
Histologic scores 7 (6–7) 40.0083 o0.001*
Group III Radiologic scores 2 (1–4) 0.002* 40.0083
Histologic scores 5 (4–6) 40.0083 40.0083
Group IV Radiologic scores 3 (3–4) 0.003* 40.0083
Histologic scores 5 (3–6) o0.001* 40.0083
n P o 0.0083 for the pairwise comparison, indicating statistical signiﬁcance.
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a study in which they investigated the fusion potential of commer-
cial DBM derivatives compared with autografts. In our study, scores
of DBM based on histologic and radiologic evaluation were inferior
compared with those obtained from the allograft group.
Studies of amniotic ﬂuid in this context showed positive effects
on cell differentiation, migration, and invasion of various cell types.7
Ozgenel et al7 suggested that amniotic ﬂuid accelerates new
cartilage formation and this could be due to the rich HA and growth
factor content of amniotic ﬂuid.7 In another study in which the
authors examined the effect of amniotic ﬂuid on cartilage formation
in pericondrial ﬂaps, Ozgenel et al18 suggested that at the end of
eighth week, amniotic factor had a positive effect on scar tissue and
new cartilage formation, most likely due to the presence of growth
factors and extracellular matrix precursors. In a study examining the
osteoblastic bone production induced by amniotic ﬂuid, Karacal
et al19 reported that bone formation was improved histopatholog-
ically when amniotic ﬂuid was applied to bone defects in rabbits at
the end of a 6-week period. In an experimental study by Aydin
et al,20 signiﬁcantly better radiologic fusion rates at 6 weeks and
signiﬁcantly better histologic fusion quality at 3 and 6 weeks were
observed in rats receiving amniotic ﬂuid. These results are consistent
with our observations, where histologic scores were statistically
signiﬁcantly better in the allograft plus amniotic ﬂuid group
compared with those in the allograft only group; however, such a
superiority was not evident in terms of radiologic scores, probably
due to low number of subjects. On the other hand, histologic and
radiologic fusion scores were not better in the DBM plus amniotic
ﬂuid group compared with those in the DBM only group, thus not
supporting beneﬁcial effects of amniotic ﬂuid on fusion when
combined with DBM. These data show that amniotic ﬂuid is effective
in enhancing vertebral fusion, particularly when combined with
allograft, probably due to its high content of several growth factors.
Both allografts and DBM are relatively more available for surgical
use compared with autografts. Furthermore, the amniotic ﬂuid used in
our study seemed to have an additional osteoinductive effect. How-
ever, cost may be a limiting factor for its use and the use of allografts
and DBM may be associated with higher treatment costs. Considering
the continuous pressure on health care providers in terms of cost-
containment strategies, the cost issue may eventually prove to be
signiﬁcant from the viewpoint of health care costs within speciﬁc
countries. On the other hand, it is also obvious that higher success and
lower nonunion rates would be expected to reduce treatment costs.Conclusions
Amniotic ﬂuid seems to have an enhancing effect on posterior
spinal fusion, particularly when combined with allograft, as shown
radiologically and histologically at the end of the eighth week. Use
of amniotic ﬂuid in this setting seems to be a promising approachin improving fusion rates and further studies are warranted to
better deﬁne its clinical role and beneﬁt.Acknowledgments
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